All Stories

Trump administration faces mounting litigation as 16 st...

Sixteen state attorneys general are suing the Department of Health and Human Ser...

Brown University set to have $510M in federal research ...

Brown University has become the fifth university to be targeted by the Trump adm...

Resmed debuts wearable, at-home sleep apnea test

The NightOwl, about the size of a quarter, is worn on the user’s index finger to...

Fierce Biotech Layoff Tracker 2025: Relay sheds staff a...

As always, if you know of layoffs occurring at a biotech, please reach out to th...

Relay Therapeutics starts third layoff wave in 1 year, ...

Relay Therapeutics has laid off about 70 employees, the biotech's third round of...

F-star charts new path, splitting from invoX after 2023...

After a drawn-out acquisition that closed in 2023, U.K. biotech F-star Therapeut...

A closer look at pharma's top R&D budgets

This week on "The Top Line," we dive into our special report ranking the top pha...

Servier severing forces OPM to make 'drastic choices' t...

Servier’s decision to exit a Parkinson’s disease pact has triggered belt tighten...

Chutes & Ladders—FDA rocked by leadership shake-ups

As the Department of Health and Human Services grapples with the fallout of mass...

Apollomics tags out of TYG oncology pact to cut costs, ...

Apollomics has tagged out of its partnership with TYG Oncology, terminating an i...

Shuren on FDA's future: 'Where do we go from here? ... ...

In a webinar hosted by the medtech development service provider NAMSA, the forme...

FDA's chief medical officer Hilary Marston is out amid ...

The FDA’s Chief Medical Officer Hilary Marston, M.D., is leaving her position at...

Eli Lilly helps struggling Sangamo with $1.4B gene ther...

Sangamo Therapeutics has secured a licensing deal with Eli Lilly that helps exte...

Cell therapy biotech Neurona nabs $102M to push epileps...

The California biotech will use the cash infusion to support its pipeline of all...

Siemens AG to acquire lab R&D platform Dotmatics for $5.1B

The German conglomerate said the deal would not only add to its work in artifici...

Fierce Biotech Fundraising Tracker '25: Neurona nabs $1...

The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 mil...

Roche shows most Alzheimer's patients below amyloid thr...

Roche has reported preliminary results on its Alzheimer’s disease prospect tront...

Aldeyra’s dry eye drug suffers second FDA rejection, bu...

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry...

BeiGene abandons ociperlimab over poor phase 3 prospect...

BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years ...

Boehringer commits $31M to ADC R&D via new Swiss facili...

Boehringer Ingelheim is pumping funds into the still-hot antibody-drug conjugate...

Cyclacel Pharmaceuticals sheds clinical cancer asset in...

Struggling Cyclacel Pharmaceuticals is dropping one of its two clinical stage as...

Concentra swoops in to buy struggling Allakos, softenin...

Tang Capital Partners-owned Concentra inked an Allakos acquisition agreement aft...

Elon Musk expected to step down from DOGE leadership ro...

In the upcoming weeks, Tesla CEO Elon Musk is expected to step down from his pos...

Elon Musk to step down from DOGE leadership role: Politico

In the upcoming weeks, Tesla CEO Elon Musk is expected to step down from his pos...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.